Salivary duct carcinoma (SDC) commonly expresses androgen receptor (AR) and HER2,
giving rise to treatment implications. SDC may also express programmed-death-ligand-1 …

Salivary duct carcinoma (SDC) is a rare, aggressive salivary gland malignancy, which often
presents at an advanced stage. A proportion of SDC are characterized by HER2 …

Salivary duct carcinoma (SDC) is an aggressive salivary gland malignancy with poor
survival. Approximately 30% SDC harbor HER2 amplification and response to trastuzumab …

Background The role of molecular markers in salivary gland carcinoma (SGC) is not well
understood. We evaluated molecular marker expression and their prognostic value …

Objectives There is currently no established algorithm for the molecular profiling of therapy‐
relevant defects in salivary gland carcinomas (SGC). HER 2 overexpression in a subfraction …

Oncocytic histologic features can be seen in a variety of salivary gland carcinomas. We
performed a comprehensive molecular profiling of 15 salivary gland malignancies with …

Salivary duct carcinoma (SDC) is aggressive with limited therapeutic options. A subset of
SDC display human epidermal growth factor receptor 2 (HER2) protein overexpression by …

Salivary duct carcinoma (SDC) is one of the most aggressive salivary gland tumors, and
prognosis remains poor for most patients. The aim of this study was to investigate the …

Salivary duct carcinoma (SDC), a rare neoplasm of the major salivary glands, is a high-
grade carcinoma with a predilection for elderly men. The authors investigated the prognostic …

Salivary duct carcinoma (SDCa) is a rare cancer with high rate of metastases and poor
survival despite aggressive multimodality treatment. This study analyzes the genetic …